ponatinib,blinatumomab
takeda,otsuka,astellas pharmaceuticals,amgen,incyte
['blinatumomab', 'leusm', 'leukemia', 'ponatinib']
watch: nicholas j. short, md, discusses updated results from a single-arm phase 2 study investigating ponatinib plus blinatumomab in patients with philadelphia chromosome positive acute lymphoblastic leukemia. #eha22 #leusm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.